Larvol Delta - Bolt-Biotherapeutics-Presents-Results-from-the-Phase-1-DoseEscalation-Clinical-Study-of-BDC3042-at-AACR-Annual-Meeting-2025

BDC-3042 - Bolt Biotherap

https://www.globenewswire.com/news-release/2025/04/25/3068520/0/en/Bolt-Biotherapeutics-Presents-Results-from-the-Phase-1-Dose-Escalation-Clinical-Study-of-BDC-3042-at-AACR-Annual-Meeting-2025.html

Apr 25, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next